Vanessa Desplat

1.7k total citations
52 papers, 1.2k citations indexed

About

Vanessa Desplat is a scholar working on Organic Chemistry, Molecular Biology and Hematology. According to data from OpenAlex, Vanessa Desplat has authored 52 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 17 papers in Molecular Biology and 13 papers in Hematology. Recurrent topics in Vanessa Desplat's work include Synthesis and Biological Evaluation (15 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Synthesis and biological activity (7 papers). Vanessa Desplat is often cited by papers focused on Synthesis and Biological Evaluation (15 papers), Antiplatelet Therapy and Cardiovascular Diseases (8 papers) and Synthesis and biological activity (7 papers). Vanessa Desplat collaborates with scholars based in France, Argentina and Italy. Vanessa Desplat's co-authors include Jean Guillon, Stéphane Moreau, Christian Jarry, Vincent Praloran, Isabelle Forfar, Stéphane Massip, Denis Thiolat, Yves Denizot, Noël Pinaud and Christian Doutremépuich and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer.

In The Last Decade

Vanessa Desplat

50 papers receiving 1.2k citations

Peers

Vanessa Desplat

HEMAT

ONCOL

IMMUN

Chris Dockendorff United States

Neelu Kaila United States

Richard M. Keenan United States

Ramesh Ummanni India

Hiroyuki Usuda Japan

Zhuang Yang China

Joachim Blanz Germany

Philip D. Edwards United States

Wolfgang von der Saal Germany

Wen‐Hsing Lin Taiwan

Chris Dockendorff United States

Vanessa Desplat

951 ×1.4

458 ×1.4

161 ×1.1

HEMAT

45 ×0.4

ONCOL

65 ×0.7

IMMUN

Citations per year, relative to Vanessa Desplat Vanessa Desplat (= 1×) peers Chris Dockendorff

Countries citing papers authored by Vanessa Desplat

Since Specialization

Citations

This map shows the geographic impact of Vanessa Desplat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Desplat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Desplat more than expected).

Fields of papers citing papers by Vanessa Desplat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Desplat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Desplat. The network helps show where Vanessa Desplat may publish in the future.

Co-authorship network of co-authors of Vanessa Desplat

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Desplat. A scholar is included among the top collaborators of Vanessa Desplat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Desplat. Vanessa Desplat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guillon, Jean, Solène Savrimoutou, Noël Pinaud, et al.. (2023). Synthesis, Crystal Structure and Anti-Leukemic Activity of (E)-Pyrrolo[1,2-a]quinoxalin-4-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one. SHILAP Revista de lepidopterología. 2023(3). M1691–M1691. 1 indexed citations

Dumas, Pierre‐Yves, Arnaud Villacreces, Amélie V. Guitart, et al.. (2021). Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in FLT3 -ITD Acute Myeloid Leukemia. Clinical Cancer Research. 27(21). 6012–6025. 24 indexed citations

Guillon, Jean, Marc Le Borgne, Charlotte Rimbault, et al.. (2013). Synthesis and biological evaluation of novel substituted pyrrolo[1,2-a]quinoxaline derivatives as inhibitors of the human protein kinase CK2. European Journal of Medicinal Chemistry. 65. 205–222. 94 indexed citations

Moreau, Stéphane, Vanessa Desplat, Solène Savrimoutou, et al.. (2012). Crystal structure of [2]benzopyrano[3,4-b]quinoxalin-5-one through spontaneous air oxidation rearrangement of 6-Chloro-isoindolo[2,1-a]quinoxaline. Comptes Rendus Chimie. 15(9). 753–757.

Desplat, Vanessa, Stéphane Moreau, Aurore Gay, et al.. (2010). Synthesis and evaluation of the antiproliferative activity of novel pyrrolo[1,2-a]quinoxaline derivatives, potential inhibitors of Akt kinase. Part II. Journal of Enzyme Inhibition and Medicinal Chemistry. 25(2). 204–215. 80 indexed citations

Desplat, Vanessa, et al.. (2009). Aspirin therapy: An attempt to explain the events of prothrombotic complications after treatment discontinuation. Thrombosis and Haemostasis. 103(1). 171–180. 10 indexed citations

Rambert, Jérôme, Maria Mamani‐Matsuda, Daniel Moynet, et al.. (2009). Molecular Blocking of CD23 Supports Its Role in the Pathogenesis of Arthritis. PLoS ONE. 4(3). e4834–e4834. 18 indexed citations

Guillon, Jean, Stéphane Moreau, Elisabeth Mouray, et al.. (2008). New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: Synthesis, and in vitro antimalarial activity. Bioorganic & Medicinal Chemistry. 16(20). 9133–9144. 101 indexed citations

Doutremépuich, Christian, et al.. (2007). Reverse Effect of Aspirin: Is the Prothrombotic Effect after Aspirin Discontinuation Mediated by Cyclooxygenase 2 Inhibition?. Pathophysiology of Haemostasis and Thrombosis. 36(1). 40–44. 23 indexed citations

10.

Guillon, Jean, Isabelle Forfar, Maria Mamani‐Matsuda, et al.. (2006). Synthesis, analytical behaviour and biological evaluation of new 4-substituted pyrrolo[1,2-a]quinoxalines as antileishmanial agents. Bioorganic & Medicinal Chemistry. 15(1). 194–210. 123 indexed citations

11.

Aguejouf, Omar, et al.. (2006). Modifications Produced by Indomethacin and <i>L</i>-NAME in the Effect of Ultralow-Dose Aspirin on Platelet Activity in Portal Hypertension. Pathophysiology of Haemostasis and Thrombosis. 35(5). 357–363. 10 indexed citations

12.

Desplat, Vanessa, Valérie Lagarde, Françis Belloc, et al.. (2004). Rapid detection of phosphotyrosine proteins by flow cytometric analysis in Bcr‐Abl–positive cells. Cytometry Part A. 62A(1). 35–45. 14 indexed citations

13.

Denizot, Yves, Vanessa Desplat, M. Drouet, François Bertin, & B. Melloni. (2001). Is there a role of platelet-activating factor in human lung cancer?. Lung Cancer. 33(2-3). 195–202. 27 indexed citations

14.

Desplat, Vanessa, et al.. (2000). Metabolism and effect of platelet-activating factor on the growth of human myeloma cell lines. Cancer Letters. 149(1-2). 7–13. 3 indexed citations

15.

Desplat, Vanessa, et al.. (2000). Effects of Lipoxygenase Metabolites of Arachidonic Acid on the Growth of Human Blood CD34+ Progenitors. Blood Cells Molecules and Diseases. 26(5). 427–436. 11 indexed citations

16.

Denizot, Yves, et al.. (1999). Arachidonic Acid and Freshly Isolated Human Bone Marrow Mononuclear Cells. Mediators of Inflammation. 8(1). 31–35. 6 indexed citations

17.

Desplat, Vanessa, et al.. (1999). Incorporation and Effect of Arachidonic Acid on the Growth of Human Myeloma Cell Lines. Mediators of Inflammation. 8(2). 115–118. 6 indexed citations

18.

Denizot, Yves, et al.. (1998). Arachidonic acid and human bone marrow stromal cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1402(2). 209–215. 14 indexed citations

19.

Desplat, Vanessa, et al.. (1998). Effects of lipoxygenase metabolites of arachidonic acid on the growth of human mononuclear marrow cells and marrow stromal cell cultures. Mediators of Inflammation. 7(1). 31–33. 9 indexed citations

20.

Desplat, Vanessa, et al.. (1997). Effects of lipidic mediators on the growth of human myeloid and erythroid marrow progenitors. PubMed. 16(3). 117–125. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact